[HTML][HTML] Diabetes and antiplatelet therapy: from bench to bedside
Diabetes mellitus (DM) is a metabolic disorder associated with accelerated atherogenesis
and an increased risk of atherothrombotic complications. Multiple mechanisms contribute to …
and an increased risk of atherothrombotic complications. Multiple mechanisms contribute to …
Aspirin in primary prevention for patients with diabetes: Still a matter of debate
A Bonaventura, L Liberale… - European Journal of …, 2018 - Wiley Online Library
Background Patients with diabetes are at high cardiovascular (CV) risk due to an
exaggerated platelet activation and aggregation. In the first 2000s low‐dose aspirin was first …
exaggerated platelet activation and aggregation. In the first 2000s low‐dose aspirin was first …
Effect of different doses of acetylsalicylic acid on the antithrombotic activity of clopidogrel in a mouse arterial thrombosis model
R Ni, N Vaezzadeh, J Zhou, JI Weitz… - … , and vascular biology, 2018 - Am Heart Assoc
Objective—Dual-antiplatelet therapy with acetylsalicylic acid and a P2Y12 antagonist, such
as clopidogrel, is the standard of care for acute coronary syndromes. However, the drugs …
as clopidogrel, is the standard of care for acute coronary syndromes. However, the drugs …
[PDF][PDF] Inhibitory effects and related mechanisms of lycium barbarum polysaccharides on vascular lesions in type 2 diabetes mellitus
G Wang, S Ju, BH Yang, CC Yan, X Cao… - Int. J. Clin. Exp …, 2018 - e-century.us
Objective: The aim of this study was to investigate the inhibitory effects and related
mechanisms of lycium barbarum polysaccharides (LBP) on type 2 diabetes mellitus (T2DM) …
mechanisms of lycium barbarum polysaccharides (LBP) on type 2 diabetes mellitus (T2DM) …